NTNX Q1 2026 Earnings Strong EPS Beat Drives Stock Surge Evaxion Q1 2026 Earnings EPS Widely Misses Estimates as ClinicalStage Biotech Continues Pipeline Investment ARM Q1 2026 Earnings EPS Beat Amidst Revenue Discrepancy Uncertainty FNLC Q1 2026 Earnings EPS of 080 Reported Amid Quiet Quarter CEG Q1 2026 Earnings Strong EPS Beat Amid Operational Excellence and Nuclear Portfolio Strength Cartesian Therapeutics RNAC Q1 2026 Earnings WiderThanAnticipated Loss Masks Progress in CART Pipeline